Spain Atopic Dermatitis Therapeutics Market Report 2022 to 2030

Spain Atopic Dermatitis Therapeutics Market Analysis

$ 3999

The Spain Atopic Dermatitis Therapeutics Market was valued at US $237 Mn in 2022, and is predicted to grow at (CAGR) of 7.8% from 2023 to 2030, to US $433 Mn by 2030. The key drivers of this industry include a surge in the prevalence of Atopic Dermatitis (AD), increased awareness and diagnosis, and lifestyle modifications. The industry is primarily dominated by players such as Pfizer, Astellas, Novartis, Bayer, AbbVie, Viatris, Leo Pharma, and Regeneron, among others.

ID: IN10ESPH435 CATEGORY: Pharmaceuticals GEOGRAPHY: Spain AUTHOR: Riddhi Solanki

Buy Now

Spain Atopic Dermatitis Therapeutics Market Analysis: Executive Summary

The Spain Atopic Dermatitis Therapeutics Market is at around US $237 Mn in 2022 and is projected to reach US $433 Mn in 2030, exhibiting a CAGR of 7.8% during the forecast period.

Atopic dermatitis, commonly referred to as eczema, is a persistent skin condition characterized by inflammation, redness, and irritation. It is not contagious and can affect individuals of all age groups, with a higher incidence often observed in childhood. Key risk factors include a personal or familial history of eczema, allergies, hay fever, or asthma. Typical symptoms include intense itching, redness, swelling, cracking, clear fluid discharge, crusting, and scaling. Management approaches for atopic dermatitis may include regular moisturizing and self-care practices, the application of medicated creams to alleviate itching and support skin repair, the use of topical or oral medications, and additional therapies such as phototherapy or immunosuppressants. Various companies, including Sanofi, Pfizer, AbbVie, Leo Pharma, Eli Lilly, and Teva Pharmaceutical, offer therapeutic options for atopic dermatitis, including topical corticosteroids, calcineurin inhibitors, and other medications designed to relieve the symptoms of the condition.

The prevalence of AD is estimated to be around 10-15% among children and approximately 3–7% in the adult population in Spain. The market is propelled by important factors such as the rising prevalence of AD, constant lifestyle modifications, and increased awareness and diagnosis in the general population. However, conditions such as high costs of treatments like biologics, a complex regulatory environment, and low treatment adherence limit the growth and potential of the market.

Market Dynamics

Market Growth Drivers

Increase in prevalence of AD: Atopic dermatitis is prevalent among a significant proportion of the Spanish populace, with projections indicating that around 10-15% of children and 3-7% of adults suffer from this condition. The increasing prevalence can be attributed to factors such as urbanization, environmental influences, and a heightened awareness of the disease.

Evolving treatment landscape: The introduction of advanced treatment choices, notably biologics, is providing patients with more efficient and enduring relief. These focused therapies are propelling the growth of the market and prompting increased expenditures because of their effectiveness. Moreover, the creation of new topical agents and oral medications with enhanced safety characteristics is broadening the array of treatment options and meeting a broader range of patient requirements.

Increased government coverage: The potential expansion of healthcare coverage for atopic dermatitis treatments in Spain, propelled by the growing impact of the disease, enhances accessibility to medications and fosters growth in the market. Additionally, the presence of national registries such as BIOBADATOP allows for robust monitoring of diagnosis and treatment.

Market Restraints

High cost of treatment: Recent biologic drugs provide substantial relief but are associated with high costs, making them inaccessible for numerous patients. The constrained coverage from public reimbursement exacerbates the limitation of access. Even when treatments are covered, patients frequently have to bear a portion of the expenses, presenting a barrier for individuals with low incomes or insufficient insurance coverage.

Low patient awareness: Atopic dermatitis is frequently misinterpreted and carries a social stigma, resulting in underdiagnosis and delayed treatment. It is imperative to conduct public awareness campaigns to enhance understanding and facilitate access to care. Effectively managing atopic dermatitis necessitates prolonged treatment and lifestyle adjustments. Inadequate adherence to treatment regimens can curtail the efficacy of medications and impede market expansion.

Increased local competition: The presence of more affordable generic alternatives to older medications can exert a negative influence on market prices, constraining profitability for companies engaged in the development of novel treatments. Patients might choose non-pharmaceutical alternatives such as moisturizers, probiotics, or dietary adjustments, thereby affecting the market share of traditional therapeutic options.

Notable Updates

October 2022, Almirall, a global biopharmaceutical company specializing in skin health, announced that the European Medicines Agency (EMA) has acknowledged the submission of the Marketing Authorization Application (MAA) for Lebrikizumab, intended for the treatment of moderate to severe atopic dermatitis in Spain.

Healthcare Policies and Regulatory Landscape

The healthcare regulatory landscape in Spain is governed by various authorities that ensure the safety, efficacy, and quality of pharmaceutical products. One of the primary regulatory bodies is the Spanish Agency of Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios, AEMPS). AEMPS operates under the Ministry of Health and is responsible for the evaluation, authorization, and supervision of drugs and healthcare products. It ensures compliance with European Union regulations and guidelines, fostering a harmonized approach to pharmaceutical oversight. The agency collaborates with the European Medicines Agency (EMA) to maintain alignment with EU standards, contributing to a cohesive regulatory environment.

Obtaining a license for pharmaceutical products in Spain involves a thorough regulatory approval process conducted by AEMPS. Applicants must submit comprehensive documentation demonstrating the safety, efficacy, and quality of their products. The regulatory pathway includes rigorous assessments of preclinical and clinical data, manufacturing processes, and labeling. Once a drug is authorized, ongoing monitoring ensures its continued safety and effectiveness in the market.

The environment for new entrants in the pharmaceutical industry in Spain is characterized by strict regulatory scrutiny, necessitating a commitment to research, development, and compliance. While the regulatory landscape ensures patient safety and product quality, it may pose challenges for new entrants, requiring a thorough understanding of the regulatory requirements and a strategic approach to navigate the approval process successfully.

Competitive Landscape

Key Players

Sanofi
Novartis
Leo Pharma
Galderma
Bayer
AbbVie
Almirall
Pfizer
AstraZeneca
Viatris

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Spain Atopic Dermatitis Therapeutics Market Segmentation

By Drug Class

Corticosteroids
Calcineurin Inhibitors
Immunosuppressants
Biologic Therapy
PDE-4 Inhibitor
Antibiotics
Antihistamines
Emollients

By Route of Administration

Topic
Oral
Injectable

By Severity type

Mild
Moderate
Severe

By Age Group

18 years and below
19 years and above

By Distribution channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Dermatology Clinics
Others

Insights10 will provide you with the reports within 10 key parameters which are:

Market Overview
Market Growth Drivers & Restraints
Epidemiology of Disease Type
Market Segmentation
Market Share
Competitive Landscape
Key Company Profiles
Healthcare Policies & Regulatory Framework
Reimbursement Scenario
Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

Establishing market drivers and trends
Analyzing the regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue/volume
Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.